BEAM
Beam Therapeutics Inc.
$24.15
-$0.86(-3.44%)
58
Overall
60
Value
72
Tech
42
Quality
Market Cap
$2.66B
Volume
1.96M
52W Range
$13.53 - $35.25
Target Price
$46.62
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Total Revenue | $24.0K | $51.8M | $60.9M | $377.7M | $63.5M | ||
| Total Revenue | $24.0K | $51.8M | $60.9M | $377.7M | $63.5M | ||
| GROSS PROFIT | |||||||
| Gross Profit | $24.0K | $51.8M | $60.9M | $377.7M | $63.5M | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $132.8M | $444.3M | $399.4M | $554.2M | $479.1M | ||
| Research & Development | $103.2M | $387.1M | $311.6M | $437.4M | $367.6M | ||
| Research Expense | $103.2M | $387.1M | $311.6M | $437.4M | $367.6M | ||
| Selling, General & Administrative | $29.6M | $57.2M | $87.8M | $116.8M | $111.5M | ||
| General & Administrative Expenses | $29.6M | $57.2M | $87.8M | $116.8M | $111.5M | ||
| Salaries & Wages | -- | -- | $84.3M | $98.6M | $120.7M | ||
| Depreciation & Amortization | $4.7M | $7.2M | $14.1M | $20.0M | $21.9M | ||
| Depreciation & Amortization | $4.7M | $7.2M | $14.1M | $20.0M | $21.9M | ||
| Other Operating Expenses | $9.3M | $21.4M | $22.9M | $36.8M | $36.9M | ||
| OPERATING INCOME | |||||||
| Operating income | $-132.8M | $-392.5M | $-338.5M | $-176.5M | $-415.6M | ||
| EBITDA | $-128.0M | $-385.0M | $-271.5M | $-101.6M | $-345.1M | ||
| NON-OPERATING ITEMS | |||||||
| Intinc | -- | -- | -- | $46.7M | $49.1M | ||
| Net Non-Operating Interest Income/Expense | -- | -- | $-15.3M | $46.7M | $49.1M | ||
| Gain on Sale of Securities | $-62.9M | $16.7M | $44.1M | $-11.1M | $-11.8M | ||
| Other Income/Expense | $61.8M | $-21.8M | $63.0M | $11.1M | $11.8M | ||
| Other Special Charges | $1.1M | $5.1M | $60.9M | $159.6M | $36.5M | ||
| SPECIAL ITEMS | |||||||
| Restructring And Mn A Income | -- | -- | -- | $6.5M | -- | ||
| Special Income Charges | -- | -- | -- | $-6.5M | -- | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-132.8M | $-392.5M | $-285.7M | $-131.2M | $-376.7M | ||
| Pre-Tax Income | $-194.6M | $-370.6M | $-260.2M | $-131.2M | $-376.7M | ||
| INCOME TAX | |||||||
| Tax Provision | -- | -- | $3.4M | $1.4M | $39.0K | ||
| NET INCOME | |||||||
| Net Income | $-194.6M | $-370.6M | $-289.1M | $-132.5M | $-376.7M | ||
| Net Income (Continuing Operations) | $-194.6M | $-370.6M | $-289.1M | $-132.5M | $-376.7M | ||
| Net Income (Discontinued Operations) | $-194.6M | $-370.6M | $-289.1M | $-132.5M | $-376.7M | ||
| Net Income (Common Stockholders) | $-195.9M | $-370.6M | $-289.1M | $-132.5M | $-376.7M | ||
| Normalized Income | -- | -- | -- | -- | $-372.9M | ||
| TOTALS | |||||||
| Total Expenses | $132.8M | $444.3M | $399.4M | $554.2M | $479.1M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $46.7M | $64.2M | $70.0M | $77.2M | $82.3M | ||
| Average Shares Outstanding (Diluted) | -- | $64.2M | $70.0M | $77.2M | $82.3M | ||
| Shares Outstanding | $62.4M | $68.7M | $72.4M | $81.7M | $83.7M | ||
| Basic EPS | $-4.19 | $-5.77 | $-4.13 | $-1.72 | $-4.58 | ||
| Basic EPS (Continuing Operations) | $-4.19 | $-5.77 | $-4.13 | $-1.72 | $-4.58 | ||
| Diluted EPS | $-4.19 | $-5.77 | $-4.13 | $-1.72 | $-4.58 | ||
| Diluted EPS (Continuing Operations) | -- | $-5.77 | $-4.13 | $-1.72 | $-4.58 | ||
| OTHER METRICS | |||||||
| Accretion On Preferred Stock | $1.3M | -- | -- | -- | -- | ||
| Earnings from equity interest | -- | -- | $-25.5M | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | -- | -- | $-25.5M | -- | -- | ||
| Other Gand A | $29.6M | $57.2M | $87.8M | $116.8M | $111.5M | ||
| Otherunder Preferred Stock Dividend | $1.3M | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $1.3M | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | $6.5M | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BEAM | $24.15 | -3.4% | 1.96M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |